中聯重科(1157.HK)漲超7% 今年累漲約50%
格隆匯2月16日丨中聯重科(1157.HK)今日再度走強,盤中股價高至13.96港元,續刷新近10年以來新高,今年以來累計漲幅約50%;現漲幅為7.43%,報13.88港元,總市值超1200億港。野村發表的研究報吿稱,重申中聯重科“買入”評級,目標價由9.8港元升至15.9港元。該行將公司2021/22財年盈利預測升15%及12%,主要因為近期針對污染、超載設施打擊較大,該行對建築機械需求看法較正面,估計旗下兩款新產品將為2021年及之後帶來顯著收入貢獻,另一方面機械升級改造週期持續等預計將改善公司現金流及資本結構,同時有助減省利息開支等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.